VTv Therapeutics shares surge 40 percent

VTv Therapeutics Inc.' stock, which took a hit last week after the company reported that a late-stage study of its Alzheimer's drug failed, has reversed course, surging more than 40 percent Tuesday afternoon. Shares of vTv Therapeutics (NASDAQ: VTVT) were up 39 cents to $1.22 as of 2:32 p.m. It's the first day the company's stock has hit above $1 since vTv Therapeutics reported disappointing results from the Phase 3 study of its drug azeliragon. The shares hit a 52-week low of 65 cents last week. VTv…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news